BACKGROUND: An increasing number of children are being referred for cardiac transplantation after (1) failing conventional corrective or palliative surgical reconstruction, (2) after stabilization with mechanical circulatory support devices, and (3) when primary graft failure or advanced cardiac allograft vasculopathy are established. METHODS: The records of 417 infants and children (age range, 0-18 years) who underwent cardiac transplantation from November 1985 through December 2005 at Loma Linda University Children's Hospital were retrospectively reviewed. The pre-transplantation diagnosis was used to divide patients into 3 groups: primary cardiomyopathy (CM), 103; hypoplastic left heart syndrome (HLHS), 154; and other complex congenital heart disease (CCHD), 160. These groups were compared and analyzed for differences in early and late morbidity and mortality. RESULTS: Operative mortality was significantly lower in the CM group compared with the HLHS (p < 0.02;) and CCHD groups (p < 0.01). Long-term actuarial recipient survival, however, was similar for all groups. The 15-year actuarial survival was 59% for the CM Group, 57% for the HLHS Group, and 50% for the CCHD Group. Actuarial survival after retransplantation is not statistically different from that with primary cardiac transplantation. CONCLUSION: Although peri-operative survival was lower in infants and children with HLHS and CCHD compared with those with CM, long-term survival has been the same for all groups. Late survival after retransplantation was not statistically different than among those with primary cardiac transplantation.
BACKGROUND: An increasing number of children are being referred for cardiac transplantation after (1) failing conventional corrective or palliative surgical reconstruction, (2) after stabilization with mechanical circulatory support devices, and (3) when primary graft failure or advanced cardiac allograft vasculopathy are established. METHODS: The records of 417 infants and children (age range, 0-18 years) who underwent cardiac transplantation from November 1985 through December 2005 at Loma Linda University Children's Hospital were retrospectively reviewed. The pre-transplantation diagnosis was used to divide patients into 3 groups: primary cardiomyopathy (CM), 103; hypoplastic left heart syndrome (HLHS), 154; and other complex congenital heart disease (CCHD), 160. These groups were compared and analyzed for differences in early and late morbidity and mortality. RESULTS: Operative mortality was significantly lower in the CM group compared with the HLHS (p < 0.02;) and CCHD groups (p < 0.01). Long-term actuarial recipient survival, however, was similar for all groups. The 15-year actuarial survival was 59% for the CM Group, 57% for the HLHS Group, and 50% for the CCHD Group. Actuarial survival after retransplantation is not statistically different from that with primary cardiac transplantation. CONCLUSION: Although peri-operative survival was lower in infants and children with HLHS and CCHD compared with those with CM, long-term survival has been the same for all groups. Late survival after retransplantation was not statistically different than among those with primary cardiac transplantation.
Authors: Oliver B Lao; Patrick J Healey; James D Perkins; Simon Horslen; Jorge D Reyes; Adam B Goldin Journal: Pediatrics Date: 2010-02-08 Impact factor: 7.124
Authors: Scott R Auerbach; Jane Gralla; David N Campbell; Shelley D Miyamoto; Biagio A Pietra Journal: Transplantation Date: 2014-02-27 Impact factor: 4.939
Authors: Scott R Auerbach; Jilayne K Smith; Jane Gralla; Max B Mitchell; David N Campbell; Jim Jaggers; Biagio A Pietra; Shelley D Miyamoto Journal: J Heart Lung Transplant Date: 2012-07-11 Impact factor: 10.247
Authors: S Urschel; P M Campbell; S R Meyer; I M Larsen; J Nuebel; J Birnbaum; H Netz; K Tinckam; T Kauke; K Derkatz; J Y Coe; J L Platt; L J West Journal: Am J Transplant Date: 2009-11-24 Impact factor: 8.086
Authors: Richard Kirk; David Naftel; Timothy M Hoffman; Christopher Almond; Gerard Boyle; Randall L Caldwell; James K Kirklin; Kirstie White; Anne I Dipchand Journal: J Heart Lung Transplant Date: 2009-09-26 Impact factor: 10.247
Authors: Alireza Raissadati; Jaana Pihkala; Timo Jahnukainen; Eero Jokinen; Hannu Jalanko; Heikki Sairanen Journal: Interact Cardiovasc Thorac Surg Date: 2016-03-30